Santeon   Report issue

For profit Phase 4
Founded: Reston VA United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2015
NCT02452151
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

infliximab (remicade) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis, Ulcerative (Phase 4)

Crohn Disease (Phase 4)

Inflammatory Bowel Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1